Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00529217 · ClinicalTrials.gov registry record · Phase 2
Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)
A Phase 2 study of Depersonalization Disorder, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00529217 is a Phase 2 study of Depersonalization Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00529217, a Phase 2 study of Depersonalization Disorder, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the clinical efficacy of transcranial magnetic stimulation in the treatment of Depersonalization Disorder (DPD).
Conditions Studied
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00529217
The ClinicalTrials.gov registry entry for NCT00529217 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depersonalization Disorder appearing as the primary indexed condition, and to 1 intervention - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.
NCT00529217 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00529217 about?
NCT00529217 is a clinical study titled "Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)". The purpose of this study is to evaluate the clinical efficacy of transcranial magnetic stimulation in the treatment of Depersonalization Disorder (DPD).
What is the current status of trial NCT00529217?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2006-05. Estimated completion is 2010-10.
What conditions does trial NCT00529217 study?
This clinical trial studies the following conditions: Depersonalization Disorder.
What interventions are being tested in trial NCT00529217?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT00529217?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00529217 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.